Globe Newswire (Mon, 12-Jan 3:31 PM ET)
NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON
PRNewswire (Mon, 12-Jan 5:30 AM ET)
PRNewswire (Mon, 5-Jan 5:30 AM ET)
Market Chameleon (Mon, 22-Dec 5:33 AM ET)
NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS
PRNewswire (Mon, 22-Dec 5:30 AM ET)
PRNewswire (Thu, 11-Dec 7:38 AM ET)
NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN
PRNewswire (Thu, 4-Dec 5:30 AM ET)
NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT
PRNewswire (Wed, 26-Nov 4:10 PM ET)
NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS
PRNewswire (Mon, 24-Nov 4:39 PM ET)
NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
PRNewswire (Wed, 19-Nov 4:30 PM ET)
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Nutex Health trades on the NASDAQ stock market under the symbol NUTX.
As of January 27, 2026, NUTX stock price declined to $154.74 with 72,568 million shares trading.
NUTX has a beta of 0.96, meaning it tends to be less sensitive to market movements. NUTX has a correlation of 0.02 to the broad based SPY ETF.
NUTX has a market cap of $1.09 billion. This is considered a Small Cap stock.
Last quarter Nutex Health reported $268 million in Revenue and $7.76 earnings per share. This beat revenue expectation by $54 million and exceeded earnings estimates by $5.81.
In the last 3 years, NUTX traded as high as $268.50 and as low as $4.16.
The top ETF exchange traded funds that NUTX belongs to (by Net Assets): VTI, AVUV, IWM, VXF, CALF.
NUTX has outperformed the market in the last year with a return of +263.8%, while the SPY ETF gained +15.7%. In the last 3 month period, NUTX beat the market returning +23.2%, while SPY returned +3.1%. However, in the most recent 2 weeks NUTX has underperformed the stock market by returning -14.4%, while SPY returned +0.1%.
NUTX support price is $149.60 and resistance is $169.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUTX shares will trade within this expected range on the day.
